Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 7025
116th Congress(2019-2020)
Diagnostic Testing for Public Health Labs Act of 2020
Introduced
Introduced
Introduced in House on May 27, 2020
Overview
Text
Introduced in House 
May 27, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(May 27, 2020)
May 27, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 7025 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 7025


To amend the Public Health Service Act to authorize grants to certain public health laboratories to assist such laboratories in meeting the cost of acquiring high-throughput diagnostic equipment, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

May 27, 2020

Mr. Bucshon introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Public Health Service Act to authorize grants to certain public health laboratories to assist such laboratories in meeting the cost of acquiring high-throughput diagnostic equipment, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Diagnostic Testing for Public Health Labs Act of 2020”.

SEC. 2. Grants for public health laboratories to acquire high-throughput diagnostic equipment.

Section 2821 of the Public Health Service Act (42 U.S.C. 300hh–31) is amended—

(1) by redesignating subsection (b) as subsection (c);

(2) in subsection (c), as so redesignated—

(A) by redesignating paragraphs (1), (2), and (3) as subparagraphs (A), (B), and (C), respectively, and moving the margin of each such redesignated subparagraph 2 ems to the right; and

(B) by striking “There are authorized to be appropriated to carry out this section” and inserting the following:

“(1) IN GENERAL.—There are authorized to be appropriated to carry out subsection (a)”;

(3) by inserting after subsection (a) the following new subsection:

“(b) Grants for public health laboratories to acquire high-Throughput diagnostic equipment.—

“(1) GRANTS.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants to eligible entities to assist such entities in purchasing high-throughput diagnostic equipment and related supplies.

“(2) ELIGIBILITY.—To be eligible for a grant under paragraph (1), an entity shall—

“(A) be—

“(i) a State, local, or Tribal public health laboratory;

“(ii) a laboratory within a public health laboratory network coordinated or managed by the Centers for Disease Control and Prevention;

“(iii) a laboratory not described in clause (i) or (ii) that the Secretary determines (at the Secretary’s discretion) provides population-based testing for the prevention and control of infectious, communicable, genetic, or chronic diseases; or

“(iv) a consortium of 2 or more entities described in any of clauses (i) through (iii); and

“(B) submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may reasonably require.

“(3) USE OF FUNDS.—Amounts received through a grant under this subsection shall be used to purchase high-throughput diagnostic equipment and such materials as are necessary to administer, store, and process applicable tests, including diagnostic and serological tests.

“(4) AMOUNT OF GRANT.—The amount of a grant under paragraph (1) may not exceed $2,000,000, except in the case of eligible entity described in paragraph (2)(A)(iv).

“(5) HIGH-THROUGHPUT DIAGNOSTIC EQUIPMENT DEFINED.—In this subsection, the term ‘high-throughput diagnostic equipment’ means legally-marketed equipment and supplies capable of performing multichannel analysis for use in clinical laboratory diagnostic testing.”; and

(4) by adding at the end of subsection (c), as redesignated, the following new paragraph:

“(2) AUTHORIZATION OF APPROPRIATIONS.—

“(A) IN GENERAL.—For the purpose of carrying out subsection (b), there is authorized to be appropriated $250,000,000 for fiscal year 2020, to remain available until expended.

“(B) ADMINISTRATIVE EXPENSES.—Of the amount made available to carry out subsection (b) for any fiscal year, the Secretary may not use more than 5 percent of such amount for the expenses of administering subsection (b).”.